Categories Earnings, LATEST, Retail

Cal-Maine Foods (NASDAQ: CALM): Q2 2020 Earnings Snapshot

— Cal-Maine Foods, Inc. (NASDAQ: CALM), a producer and marketer of shell eggs, reported a loss of $0.21 per share for the second quarter of 2020, compared to earnings of $0.45 per share last year, vs. $0.03 per share earnings analysts estimated.

— Second-quarter net loss was $10.06 million, compared to a profit of $21.81 million in the same period of last year

— Net sales decreased to $311.52 million from $356.04 million last year, vs. $327.04 million expected

Sold 261,026 dozen eggs in the second quarter, compared to 262,263 dozen last year

— Net average selling price per dozen was $1.160, compared to $1.311 in the second quarter of 2019

— Expects to improve operations by leveraging new capacity additions and planned closure of underperforming facilities

— On track to position the company as an industry leader in meeting future customer requirements for cage-free eggs

— Completed acquisition of the commercial shell eggs business of Mahard Egg Farm, which will be integrated into Cal-Maine’s existing footprint in the South Central region

— Expects more price volatility in the second half, due to headwinds from uncertainties related to trade agreements and tariffs disputes

We’re on Apple News! Follow us to receive the latest stock market, earnings and financial news at your fingertips

Most Popular

BLK Earnings: BlackRock Q2 2024 profit jumps on higher revenues

Asset management company BlackRock, Inc. (NYSE: BLK) on Monday reported a double-digit increase in adjusted profit for the second quarter of 2024, aided by an 8% increase in revenues. Second-quarter

GS Earnings: All you need to know about Goldman Sachs’ Q2 2024 earnings results

The Goldman Sachs Group, Inc. (NYSE: GS) reported its second quarter 2024 earnings results today. Net revenues were $12.73 billion, up 17% compared to the same period a year ago,

Intuitive Surgical likely to report strong revenue, profit growth for Q2 2024

Intuitive Surgical, Inc. (NASDAQ: ISRG) is expected to report its second-quarter earnings next week, amid expectations for strong revenue and profit growth. The medical device maker is thriving on the

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top